Funded Startups in Norcross
Norcross-based deal flow in these 8 most recent entries is shaped by one large disclosed round: McLarens raised $1.6B on 2025-10-16, which dwarfs the next-…
Norcross-based deal flow in these 8 most recent entries is shaped by one large disclosed round: McLarens raised $1.6B on 2025-10-16, which dwarfs the next-largest disclosed amounts shown ($11M on 2023-10-25 for Renew Digital; $10M on 2025-07-09 for Galectin Therapeutics; $3M for WEAV3D on 2025-05-27 and Sanguina on 2023-07-25). Disclosed amounts also cluster tightly at the single-digit to low tens of millions for most companies, while two entries list undisclosed amounts (GlobalMed Logistix on 2026-01-21; Koning on 2025-05-22; Stratix Corporation on 2022-09-16).
The timeline shows a mid-to-late 2025 concentration: 5 of 8 rounds fall between 2025-05-22 and 2025-10-16 (WEAV3D, Koning, Galectin Therapeutics, McLarens, and GlobalMed Logistix as the most recent on 2026-01-21). Sector representation is fragmented, but Health Care, Biotechnology, Manufacturing, Hardware, Insurance/Finance/Professional Services, and Consumer Electronics each appear once; stage labels are split across Series A (Sanguina, 2023-07-25), Series C (Koning, undisclosed amount), and “Series Unknown” (including GlobalMed Logistix, Galectin Therapeutics, WEAV3D, Renew Digital).
Most recent rounds
8 shownRelated listings
Frequently asked
What’s the largest disclosed round among the most recent Norcross entries, and how does it compare to the rest?
McLarens’ $1.6B (2025-10-16) is an outlier against all other disclosed amounts shown, where the next-largest disclosed figures are $11M (Renew Digital, 2023-10-25) and $10M (Galectin Therapeutics, 2025-07-09). Most other disclosed rounds are $3M or $1.6B is far above the displayed range.
Do these Norcross deals cluster around a particular time window?
Yes. Five of the eight rows have round dates between 2025-05-22 and 2025-10-16 (Koning, WEAV3D, Galectin Therapeutics, McLarens, and Renew Digital falls outside that window but the rest of the cluster is concentrated in that mid-2025 period). The most recent row is GlobalMed Logistix on 2026-01-21, while the oldest is Stratix Corporation on 2022-09-16.
How much of the list is undisclosed vs. disclosed, and does that affect comparisons?
Three of eight entries show undisclosed amounts (GlobalMed Logistix on 2026-01-21; Koning on 2025-05-22; Stratix Corporation on 2022-09-16). Among the remaining five disclosed rows, the spread runs from $3M (WEAV3D, 2025-05-27; Sanguina, 2023-07-25) up to the $1.6B McLarens round (2025-10-16), making the disclosed dataset especially sensitive to that one large outlier.
Which stage labels show up most often in this set?
“Series Unknown” appears in four of the eight entries: GlobalMed Logistix (2026-01-21, undisclosed), Galectin Therapeutics (2025-07-09, $10M), WEAV3D (2025-05-27, $3M), and Renew Digital (2023-10-25, $11M). The remaining labeled stages are Series C (Koning, 2025-05-22, undisclosed), Series A (Sanguina, 2023-07-25, $3M), and Private Equity (McLarens on 2025-10-16 for $1.6B; Stratix Corporation on 2022-09-16, undisclosed).
Are there sector patterns or notable cross-sector outliers in this slice of Norcross?
Sector coverage is broad rather than concentrated: Biotechnology (Galectin Therapeutics, $10M on 2025-07-09) and Health Care (GlobalMed Logistix, undisclosed on 2026-01-21) each appear once, as do Manufacturing (WEAV3D, $3M on 2025-05-27) and Hardware (Renew Digital, $11M on 2023-10-25). The clearest outlier is sector-linked to the largest disclosed round: Insurance/Finance/Professional Services via McLarens’ $1.6B on 2025-10-16, far above the other disclosed amounts in unrelated sectors.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.